[미국특허]
Methods for detecting nucleic acids encoding human telomerase reverse transcriptase
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12Q-001/68
C12N-009/12
C07H-021/04
C07H-021/00
C07H-021/02
출원번호
US-0054611
(2002-01-18)
발명자
/ 주소
Cech,Thomas R.
Lingner,Joachim
Nakamura,Toru
Chapman,Karen B.
Morin,Gregg B.
Harley,Calvin B.
Andrews,William H.
출원인 / 주소
Geron Corporation
The Regents of the University of Colorado
대리인 / 주소
Townsend Townsend &
인용정보
피인용 횟수 :
12인용 특허 :
31
초록▼
The present invention is directed to methods of identifying in a sample nucleic acids that encode human telomerase reverse transcriptase (hTRT) or its fragments. The present invention is also directed to oligonucleotide primers used in such methods. The invention is further directed to PCR products
The present invention is directed to methods of identifying in a sample nucleic acids that encode human telomerase reverse transcriptase (hTRT) or its fragments. The present invention is also directed to oligonucleotide primers used in such methods. The invention is further directed to PCR products that hybridize under stringent conditions to a polynucleotide encoding hTRT, as well as hybridization complexes comprising one strand of a cellular hTRT nucleic acid and one strand of nucleic acid comprising a recombinant or synthetic fragment of hTRT.
대표청구항▼
What is claimed is: 1. A method of identifying a nucleic acid that encodes human telomerase reverse transcriptase (hTRT) or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide probe such that the probe hybridizes specifically to the nucleic acid if the nucleic ac
What is claimed is: 1. A method of identifying a nucleic acid that encodes human telomerase reverse transcriptase (hTRT) or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide probe such that the probe hybridizes specifically to the nucleic acid if the nucleic acid encodes hTRT or fragment thereof: b) detecting any hybrid formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the hybrid is detected; wherein the probe hybridizes specifically to a DNA having the sequence of the hTRT encoding region of SEQ. ID NO:224 at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl but does not hybridize to a DNA having the sequence of SEQ. ID NO:62 under the same reaction conditions; wherein Tm is the melting temperature of double-stranded DNA having the sequence of said encoding region under the same reaction conditions. 2. A method of detecting a nucleic acid that encodes hTRT or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide probe such that the probe hybridizes specifically to a nucleic acid comprising at least 100 consecutive nucleotides contained in SEQ. ID NO:224 it present in the sample: b) detecting any hybrid formed as a result of a), and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the hybrid is detected; wherein the polynucleotide probe consists essentially of a sequence identical or complementary to 25 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224 that are not contained in SEQ. ID NO:62. 3. The method of claim 2, wherein the hTRT nucleic acid is human genomic DNA. 4. The method of claim 2, wherein the hTRT nucleic acid is mRNA or cDNA. 5. The method of claim 2, wherein the hTRT nucleic acid consists essentially of 250 or more nucleotides of SEQ. ID NO:224. 6. The method of claim 2, wherein the hTRT nucleic acid consists essentially of 500 or more nucleotides of SEQ. ID NO:224. 7. The method of claim 2, wherein the probe consists essentially of a sequence identical or complementary to 30 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 8. The method of claim 2, wherein the probe consists essentially of a sequence identical or complementary to 50 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 9. The method of claim 2, wherein the probe consists essentially of a sequence identical or complementary to 100 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 10. A method of identifying a nucleic acid that encodes hTRT or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide primer under conditions that the primer specifically primes amplification of SEQ. ID NO:224 or fragment thereof if present in the sample; b) detecting any amplification product formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the amplification product is detected; wherein the primer hybridizes specifically to a DNA having the sequence of the hTRT encoding region of SEQ. ID NO:224 at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl, but does not hybridize to a DNA having the sequence of SEQ. ID NO:62 under the same reaction conditions; wherein Tm is the melting temperature of double-stranded DNA having the sequence of said encoding region under the same reaction conditions. 11. A method of detecting a nucleic acid encoding hTRT or fragment thereof in a sample, comprising: a) combining the sample with polynucleotide primers so as to prime amplification of nucleic acid encoding hTRT or fragment thereof if present in the sample; b) detecting any amplified product formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the amplification product is detected: wherein each of said primers consists essentially of a sequence identical or complementary to 15 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224, but at least one of the primers does not consist sequence identical or complementary to 15 or more consecutive nucleotides from SEQ. ID NO:62. 12. The method of claim 11, wherein each of said primers consists essentially of a sequence identical or complementary to 30 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 13. The method of claim 11, wherein each of said primers consists essentially of a sequence identical or complementary to 50 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 14. The method of claim 1, wherein a) comprises combining the sample with the probe at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl. 15. The method of claim 1, wherein the probe comprises a sequence identical or complementary to 100 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 16. The method of claim 1, wherein the sample has been taken from a patient having a tumor. 17. The method of claim 2, wherein the sample has been taken from a patient having a tumor. 18. The method of claim 10, wherein a) comprises combining the sample with the primer at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl. 19. The method of claim 10, wherein the primer comprises a sequence identical or complementary to 30 or more consecutive nucleotides from the hTRT encoding region of SEQ. ID NO:224. 20. The method of claim 10, wherein the sample has been taken from a patient having a tumor. 21. The method of claim 11, wherein the sample has been taken from a patient having a tumor. 22. A method of identifying a nucleic acid that encodes human telomerase reverse transcriptase (hTRT) or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide probe such that the probe hybridizes specifically to the nucleic acid if the nucleic acid encodes hTRT or fragment thereof; b) detecting any hybrid formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the hybrid is detected; wherein the probe hybridizes specifically to a DNA having a sequence consisting of SEQ. ID NO:62 at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl; wherein Tm is the melting temperature of double-stranded DNA having the sequence of SEQ. ID NO:62 under the same reaction conditions. 23. The method of claim 22, wherein a) comprises combining the sample with the probe at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl. 24. The method of claim 22, wherein the probe comprises a sequence identical or complementary to 100 or more consecutive nucleotides from SEQ. ID NO:62. 25. The method of claim 22, wherein the probe is a fragment of SEQ. ID NO:62. 26. The method of claim 22, wherein the sample has been taken from a patient having a tumor. 27. A method of detecting a nucleic acid that encodes hTRT or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide probe such that the probe hybridizes specifically to a nucleic acid comprising at least 100 consecutive nucleotides contained in SEQ. ID NO:62 if present in the sample: b) detecting any hybrid formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the hybrid is detected; wherein the polynucleotide probe consists essentially of a sequence identical or complementary to 25 or more consecutive nucleotides from SEQ. ID NO:62. 28. The method of claim 27, wherein the probe consists essentially of a sequence identical or complementary to 30 or more consecutive nucleotides from SEQ. ID NO:62. 29. The method of claim 27, wherein the probe consists essentially of a sequence identical or complementary to 50 or more consecutive nucleotides from SEQ. ID NO:62. 30. The method of claim 27, wherein the probe consists essentially of a sequence identical or complementary to 100 or more consecutive nucleotides from SEQ. ID NO:62. 31. The method of claim 27, wherein the sample has been taken from a patient having a tumor. 32. A method of identifying a nucleic acid that encodes hTRT or fragment thereof in a sample, comprising: a) combining the sample with a polynucleotide primer under conditions that the primer specifically primes amplification of SEQ. ID NO:62 or fragment thereof if present in the sample; b) detecting any amplification product formed as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the amplification product is detected; wherein the primer hybridizes specifically to a DNA having a sequence consisting of SEQ. ID NO:62 at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl; wherein Tm is the melting temperature of double-stranded DNA having the sequence of SEQ. ID NO:62 under the same reaction conditions. 33. The method of claim 32, wherein a) comprises combining the sample with the primer at 5째 C. to 25째 C. below Tm in aqueous solution at 1 M NaCl. 34. The method of claim 32, wherein the primer comprises a sequence identical or complementary to 30 or more consecutive nucleotides from SEQ. ID NO:62. 35. The method of claim 32, wherein the probe is a fragment of SEQ. ID NO:62. 36. The method of claim 32, wherein the sample has been taken from a patient having a tumor. 37. A method of detecting a nucleic acid encoding hTRT or fragment thereof in a sample, comprising: a) combining the sample with polynucleotide primers so as to prime amplification of nucleic acid encoding hTRT or fragment thereof it present in the sample: b) detecting any amplified product fanned as a result of a); and c) identifying the nucleic acid as encoding hTRT or fragment thereof if the amplification product is detected; wherein each of said primers consists essentially of a sequence identical or complementary to 15 or more consecutive nucleotides from SEQ. ID NO:62. 38. The method of claim 37, wherein each of said primers consists essentially of a sequence identical or complementary to 30 or more consecutive nucleotides from SEQ. ID NO:62. 39. The method of claim 37, wherein each of said primers consists essentially of a sequence identical or complementary to 50 or more consecutive nucleotides from SEQ. ID NO:62. 40. The method of claim 37, wherein the sample has been taken from a patient having a tumor.
Thomas R. Cech ; Joachim Lingner CH; Toru Nakamura ; Karen B. Chapman ; Gregg B. Morin ; Calvin B. Harley ; William H. Andrews, Antisense compositions for detecting and inhibiting telomerase reverse transcriptase.
Cech, Thomas R.; Lingner, Joachim; Nakamura, Toru; Chapman, Karen B.; Morin, Gregg B.; Harley, Calvin B.; Andrews, William H., Cells immortalized with telomerase reverse transcriptase for use in drug screening.
Thomas R. Cech ; Joachim Lingner CH; Toru Nakamura ; Karen B. Chapman ; Gregg B. Morin ; Calvin B. Harley ; William H. Andrews, Human telomerase catalytic subunit: diagnostic and therapeutic methods.
Mullis Kary B. (La Jolla CA) Erlich Henry A. (Oakland CA) Gelfand David H. (Oakland CA) Horn Glenn (Emeryville CA) Saiki Randall K. (Richmond CA), Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme.
Mullis Kary B. (Kensington CA) Erlich Henry A. (Oakland CA) Arnheim Norman (Woodland Hills CA) Horn Glenn T. (Emeryville CA) Saiki Randall K. (Richmond CA) Scharf Stephen J. (Berkeley CA), Process for amplifying, detecting, and/or-cloning nucleic acid sequences.
Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
Diamond Paul (693 Somerville Ave. ; Apt. 4 Somerville MA 02143), Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases.
West Michael D. (Belmont CA) Shay Jerry (Dallas TX) Wright Woodring (Arlington TX), Therapy and diagnosis of conditions related to telomere length and/or telomerase activity.
Cech, Thomas R.; Lingner, Joachim; Nakamura, Toru M.; Chapman, Karen B.; Morin, Gregg B.; Harley, Calvin B.; Andrews, William H., Method for eliciting an immune response to human telomerase reverse transcriptase.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.